Obsidian Therapeutics, Inc.
OBX
$17.77
-$1.15-6.08%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -19.63M | -24.99M | |||
| Total Depreciation and Amortization | 340.00K | 378.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 1.14M | 1.21M | |||
| Change in Net Operating Assets | -3.86M | -965.00K | |||
| Cash from Operations | -22.01M | -24.37M | |||
| Capital Expenditure | -- | -56.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 8.00M | 13.56M | |||
| Cash from Investing | 8.00M | 13.50M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 47.00K | 6.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 47.00K | 6.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -13.97M | -10.86M | |||